返回
CARsgen Therapeutics Holdings Ltd（02171.HK）價格
02171.HK 股價走勢圖
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Ltd
HK$15.07
1.14%
$0.16
休市： Feb 16, 12:00:00 HKT
關鍵數據
前收市價
$14.4
開盤價
$14.9
當日範圍
$14.44 - $15.52
52週區間
$8.5 - $25.6
交易量
--
平均成交量
1.7M
每股盈餘 (TTM)
-1.06
股息收益率
--
市值
$8.2B
什麼是 CARSGEN-B？
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.
